Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe
Mike Sharland, C. Pulcini, Stephan Harbarth, et al.
The Lancet Infectious Diseases (2017) Vol. 18, Iss. 1, pp. 18-20
Open Access | Times Cited: 204

Showing 1-25 of 204 citing articles:

COVID-19 and the potential long-term impact on antimicrobial resistance
Timothy M. Rawson, Luke Moore, Enrique Castro‐Sánchez, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 75, Iss. 7, pp. 1681-1684
Open Access | Times Cited: 306
Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries
Yingfen Hsia, Brian Lee, Ann Versporten, et al.
The Lancet Global Health (2019) Vol. 7, Iss. 7, pp. e861-e871
Open Access | Times Cited: 293
Antimicrobial use, drug-resistant infections and COVID-19
Timothy M. Rawson, Damien Ming, Raheelah Ahmad, et al.
Nature Reviews Microbiology (2020) Vol. 18, Iss. 8, pp. 409-410
Open Access | Times Cited: 255
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage
Angela Huttner, Julia Bielicki, Michelle Clements, et al.
Clinical Microbiology and Infection (2019) Vol. 26, Iss. 7, pp. 871-879
Open Access | Times Cited: 186
Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries
Brian Godman, Abiodun Egwuenu, Mainul Haque, et al.
Life (2021) Vol. 11, Iss. 6, pp. 528-528
Open Access | Times Cited: 179
Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries
Yingfen Hsia, Mike Sharland, Charlotte Jackson, et al.
The Lancet Infectious Diseases (2018) Vol. 19, Iss. 1, pp. 67-75
Open Access | Times Cited: 167
Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool
Mike Sharland, Sumanth Gandra, Benedikt Huttner, et al.
The Lancet Infectious Diseases (2019) Vol. 19, Iss. 12, pp. 1278-1280
Open Access | Times Cited: 150
The <i>WHO AWaRe (Access, Watch, Reserve) antibiotic book</i> and prevention of antimicrobial resistance
Veronica Zanichelli, Mike Sharland, Bernadette Cappello, et al.
Bulletin of the World Health Organization (2023) Vol. 101, Iss. 04, pp. 290-296
Open Access | Times Cited: 112
Iron Oxide Nanoparticles: Preparation, Characterization, and Assessment of Antimicrobial and Anticancer Activity
Abdulaziz Alangari, Mohammed S. Alqahtani, Ayesha Mateen, et al.
Adsorption Science & Technology (2022) Vol. 2022
Open Access | Times Cited: 72
World Health Organization AWaRe framework for antibiotic stewardship: Where are we now and where do we need to go? An expert viewpoint
Steward Mudenda, Victor Daka, Scott Kaba Matafwali
Antimicrobial Stewardship & Healthcare Epidemiology (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 44
Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future
Brian Godman, Mainul Haque, Judy McKimm, et al.
Current Medical Research and Opinion (2019) Vol. 36, Iss. 2, pp. 301-327
Open Access | Times Cited: 139
The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis
Olaniyi Ayobami, Niklas Willrich, Thomas Harder, et al.
Emerging Microbes & Infections (2019) Vol. 8, Iss. 1, pp. 1747-1759
Open Access | Times Cited: 124
A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications
Zikria Saleem, Mohamed Azmi Hassali, Ann Versporten, et al.
Expert Review of Anti-infective Therapy (2019) Vol. 17, Iss. 4, pp. 285-293
Open Access | Times Cited: 102
How to improve antibiotic awareness campaigns: findings of a WHO global survey
Benedikt Huttner, Mirko Saam, Lorenzo Moja, et al.
BMJ Global Health (2019) Vol. 4, Iss. 3, pp. e001239-e001239
Open Access | Times Cited: 94
Timing of DNA damage responses impacts persistence to fluoroquinolones
Wendy W. K. Mok, Mark P. Brynildsen
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 27
Open Access | Times Cited: 87
Sale of WHO AWaRe groups antibiotics without a prescription in Pakistan: a simulated client study
Zikria Saleem, Mohamed Azmi Hassali, Brian Godman, et al.
Journal of Pharmaceutical Policy and Practice (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 87
Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil
Matheus Polly, Bianca Leal de Almeida, Robert P. Lennon, et al.
American Journal of Infection Control (2021) Vol. 50, Iss. 1, pp. 32-38
Open Access | Times Cited: 85
Comparative assessment of the prevalence, practices and factors associated with self‐medication with antibiotics in Africa
Eugene Vernyuy Yeika, Brecht Ingelbeen, Ben‐Lawrence Kemah, et al.
Tropical Medicine & International Health (2021) Vol. 26, Iss. 8, pp. 862-881
Open Access | Times Cited: 77
Setting the standard: multidisciplinary hallmarks for structural, equitable and tracked antibiotic policy
Claas Kirchhelle, Paul Atkinson, Alex Broom, et al.
BMJ Global Health (2020) Vol. 5, Iss. 9, pp. e003091-e003091
Open Access | Times Cited: 74
Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship
Daniel Kwame Afriyie, Israel Abebrese Sefah, Jacqueline Sneddon, et al.
JAC-Antimicrobial Resistance (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 72
Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries
Brian Godman, Holly McCabe, Trudy Leong, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2020) Vol. 20, Iss. 1, pp. 1-26
Open Access | Times Cited: 69
A global point prevalence survey of antimicrobial use in neonatal intensive care units: The no-more-antibiotics and resistance (NO-MAS-R) study
Pavel Prusakov, Debra A. Goff, Phillip S. Wozniak, et al.
EClinicalMedicine (2021) Vol. 32, pp. 100727-100727
Open Access | Times Cited: 67
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications
Zikria Saleem, Brian Godman, Faiza Azhar, et al.
Expert Review of Anti-infective Therapy (2021) Vol. 20, Iss. 1, pp. 71-93
Open Access | Times Cited: 63
Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis
Kristin L. Andrejko, Buddhika Ratnasiri, William P. Hausdorff, et al.
The Lancet Microbe (2021) Vol. 2, Iss. 9, pp. e450-e460
Open Access | Times Cited: 63
Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future
Zikria Saleem, Brian Godman, Aislinn Cook, et al.
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1824-1824
Open Access | Times Cited: 59
Page 1 - Next Page

Scroll to top